IP Library › Granted Patent US 8,435,794
Granted Patent B2
US 8,435,794 · App. 12/741,434 · Granted May 7, 2013

Colorimetric test for antimalarial artemesin derivatives

Inventor: Michael D. Green (Winder, GA)
Assignee: The United States of America, as Represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,435,794
App. No.
12/741,434
Granted
May 7, 2013
Kind
B2
Abstract

A process for testing a composition as containing an artemisinin derivative is provided that includes contacting the composition with a reagent made up of a hydrogen bonding polar organic solvent and an acid having a pK value of less than 3.8 at 25° Celsius and capable of acid catalyzing a decomposition reaction of the artemisinin derivative so as to provide a reaction mixture. The reaction mixture is allowed sufficient time at a reaction temperature for the artemisinin derivative to decompose to yield a colored decomposition product discerned by a normal unaided human eye. A kit for testing a composition for an artemisinin derivative according to the process is provided together with instructions for contacting the solvent and the acid with the composition to decompose the artemisinin derivative to yield the colored decomposition.

Claims (14)

1. A process for testing a composition for the presence of an artemisinin derivatives comprising:

contacting the composition with a reagent, said reagent consisting of a hydrogen bonding polar organic solvent and an acid having a pK value of less than 3.8 at 25° Celsius and catalyzing acid decomposition of the artemisinin derivative; and

allowing sufficient time at a reaction temperature for the artemisinin derivative to decompose to yield a colored decomposition product discernable by a normal unaided human eye.

2. The process of claim 1 wherein said colored decomposition product is green.

3. The process of claim 2 wherein said colored decomposition product has a visual intensity that is proportional to concentration.

4. The process of claim 1 wherein the composition comprises the artemisinin derivative and at least one component of tablet adjuvants, antimicrobials, non-artemisinin derivative antimalarials and nonsteroidal anti-inflammatories.

5. The process wherein said hydrogen bonding polar organic solvent is methanol, ethanol, methylcellusolve, acetonitrile, acetic acid, acetone, or a combination thereof.

6. The process of claim 1 wherein said hydrogen bonding polar organic solvent is methanol.

7. The process of claim 1 wherein said hydrogen bonding organic solvent is acetic acid or phosphoric acid.

8. The process of claim 1 wherein the reaction temperature of the reaction mixture is between 30 and 40° Celsius and a boiling temperature of said hydrogen bonding polar organic solvent.

9. The process of claim 8 wherein the reaction temperature is between 30 and 40° Celsius and the reaction time is from 2 to 15 minutes.

10. The process of claim 1 further comprising abrading the composition from an oral dosage.

11. The process of claim 1 wherein contact between the composition and said reagent is through dissolution of the composition in said reagent.

12. The process of claim 1 wherein the composition comprises artesunate and further comprising contacting a second portion of the composition with water and a pH indicator showing a color change at pH between 3.5 and 4.0.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2010
From: GREEN, MICHAEL D.
To: THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION
Reel/Frame 024808/0194 →
Continuity (2)
Provisional Application 60985399 · Nov 5, 2007
Related Publication 20100297775A1 · Nov 25, 2010